[PDF][PDF] Progress in target therapy of advanced non-small cell lung cancer
L Zhang, R Cao - tmrjournals.cn
Lung cancer is one of the most common malignant tumors, and its morbidity and mortality
are relatively high. Especially for small cell lung cancer (SCLC), the mortality rate is between …
are relatively high. Especially for small cell lung cancer (SCLC), the mortality rate is between …
[HTML][HTML] Breakthrough in targeted therapy for non-small cell lung cancer
Z Ye, Y Huang, J Ke, X Zhu, S Leng, H Luo - Biomedicine & …, 2021 - Elsevier
Non-small cell lung cancer (NSCLC) remains by far the single most common malignancy of
lung cancer which causes more and more mortality in recent years. NSCLC accounts for …
lung cancer which causes more and more mortality in recent years. NSCLC accounts for …
The progress of molecular-targeted therapeutic drugs in non-small cell lung cancer
J Jin, J HE, L Zhou - Chinese Journal of Clinical Oncology, 2015 - pesquisa.bvsalud.org
Lung cancer is ranked the first among all malignant neoplastic diseases because of its high
morbidity and mortality rate. Thus, lung cancer seriously threatens human health. More than …
morbidity and mortality rate. Thus, lung cancer seriously threatens human health. More than …
[HTML][HTML] Targeted therapies for advanced non-small cell lung cancer
Lung cancer is a serious health problem and the leading cause of cancer death worldwide,
due to its high incidence and mortality. 85% of lung cancers are represented by the non …
due to its high incidence and mortality. 85% of lung cancers are represented by the non …
Targeted therapy in non-small cell lung cancer
SC Tang - Zhongguo Fei Ai Za Zhi, 2004 - search.proquest.com
Recent progress in molecular biology has enabled us to better understand the molecular
mechanism underly ing pathogenesis of human malignancy including lung cancer …
mechanism underly ing pathogenesis of human malignancy including lung cancer …
Recent advances in non-small cell lung cancer targeted therapy; an update review
Lung cancer continues to be the leading cause of cancer-related death worldwide. In the last
decade, significant advancements in the diagnosis and treatment of lung cancer, particularly …
decade, significant advancements in the diagnosis and treatment of lung cancer, particularly …
A pharmacological exploration of targeted drug therapy in non-small cell lung cancer
AP Jayan, KR Anandu, K Madhu, VN Saiprabha - Medical Oncology, 2022 - Springer
Lung cancer is the prime cause of cancer-related deaths globally, with a contribution of 85%
from non-small cell lung cancer. Before a few decades back, conventional chemotherapy …
from non-small cell lung cancer. Before a few decades back, conventional chemotherapy …
[HTML][HTML] Recent advances in molecular targeted therapy of lung cancer: Possible application in translation medicine
E Salmani-Javan, MFS Jadid… - Iranian Journal of Basic …, 2024 - ncbi.nlm.nih.gov
Lung cancer is one of the leading causes of death among all cancer deaths. This cancer is
classified into two different histological subtypes: non-small cell lung cancer (NSCLC), which …
classified into two different histological subtypes: non-small cell lung cancer (NSCLC), which …
Current Pharmacological Aspects of Treating Lung Cancers
Y Yamazaki - dea.lib.unideb.hu
Lung cancer is the leading cause of mortality. As life expectancy is prolonged, morbidity of
lung cancer is increased. As of 2023, various mechanisms of molecularly-targeted drugs are …
lung cancer is increased. As of 2023, various mechanisms of molecularly-targeted drugs are …
Molecular targeted therapy in lung cancer
MJ Ahn - Hanyang Medical Reviews, 2014 - synapse.koreamed.org
Lung cancer is the most common cause of cancer death worldwide. With advances in
understanding of lung cancer biology and technology, there has been significant …
understanding of lung cancer biology and technology, there has been significant …